Results 231 to 240 of about 98,141 (333)

Malignant Transformation of Oral Leukoplakia and Proliferative Verrucous Leukoplakia and Its Biomarker Predictors: A Systematic Umbrella Review

open access: yesHead &Neck, Volume 48, Issue 1, Page 246-260, January 2026.
ABSTRACT Background Oral leukoplakia (OL) represents the most common oral potentially malignant disorder globally, with highly variable reported malignant transformation (MT) rates creating challenges for evidence‐based clinical management. Objective To systematically synthesize evidence on MT prevalence in OL and evaluate potential predictive ...
Mohammed Taib Fatih   +13 more
wiley   +1 more source

Genetic Screening for Aneuploidy in the Second-trimester

open access: bronze, 2008
Marianna Theodora, A. Antsaklis
openalex   +1 more source

Navigating the evolving management of smoldering multiple myeloma

open access: yesHemaSphere, Volume 10, Issue 1, January 2026.
Abstract Smoldering multiple myeloma (SMM) represents an intermediate clinical stage between monoclonal gammopathy of undetermined significance (MGUS) and symptomatic multiple myeloma (MM). SMM carries a highly variable risk of progression to MM, requiring individualized risk stratification to guide management.
M. Bakri Hammami   +6 more
wiley   +1 more source

Deletion of the Mis12C-Binding Domain of CENP-C Promotes Chromosomal Aneuploidy in Cutaneous Squamous Cell Carcinoma. [PDF]

open access: yesCancer Sci
Saito M   +10 more
europepmc   +1 more source

Triage and care for women with symptoms or diagnosis of pregnancy loss between 14 + 0 and 21 + 6 weeks' gestation

open access: yesInternational Journal of Gynecology &Obstetrics, Volume 172, Issue 1, Page 25-50, January 2026.
Abstract Mid‐trimester pregnancy loss (MTL), defined as a pregnancy loss occurring between 14 + 0 and 21 + 6 weeks of gestation, causes significant physical and emotional distress to women and presents clinical challenges to healthcare professionals. It is acknowledged that in low‐resource settings, this guideline might be applicable to births up to 28 
Caroline E. Fox   +46 more
wiley   +1 more source

Low-Set Ears: A New Marker of Fetal Chromosomal Anomalies.

open access: yesFetal Diagn Ther
Baldrich-Martin E   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy